Near-total removal of facial nerve schwannomas: long-term outcomes




Abstract


Objective


The study aimed to present long-term outcomes of near-total removal of facial nerve schwannomas (FNS) with good facial nerve function (HB Grade III or better).


Methods


We successfully performed near-total removal of FNS (tumor removal of 95% or greater) on 13 cases, and the remaining 6 cases who failed underwent total tumor removal and nerve grafting. Patients were divided into near-total removal group and total removal group according to surgical approach, and they were followed up for 7.38 ± 1.98 years (range, 5 to 11 years) and 6.66 ± 1.63 years (range, 5 to 9 years), respectively.


Results


12 of 13 cases (92.3%) in the near-total removal group successfully maintained at least Grade III except one who recurred and underwent complete tumor removal and nerve grafting, and 10 cases (76.9%) achieved Grade I or Grade II. 5 of 6 cases (83.3%) in the total removal group obtained Grade III, but none recovered to Grade I or II. Tumor growth was noted in only one case (7.7%) among the near-total removal group during the follow-up.


Conclusions


Long-term outcomes of near-total removal of FNS were favorable, which may be a good choice for the old patients with good facial nerve function.



Introduction


Facial nerve schwannomas (FNS) are rare entities. There is no clear consensus about treatment. Currently, most authors agree that the ultimate goal is to preserve facial nerve function due to the slow-growing and benign nature of the tumors. Total tumor removal and nerve grafting undoubtedly result in Grade III (House–Brackmann grading system ) recovery at best , thus subtotal removal, observation, stereotactic radiosurgery or facial nerve decompression sole is recommended to the patients with good facial nerve function (Grade III or better), since good outcomes of facial nerve could be maintained for a time .


The purpose of the current study was to report long-term outcomes of near-total removal of FNS and discuss about its application.





Materials and methods


A consecutive series of 19 FNS patients with good facial nerve function was involved in the study, among which 11 were female and 8 male. The mean age was 36.20 ± 3.22 years (range, 18 to 72 years). We successfully carried out near-total removal of FNS (defined as tumor removal of 95 percentage or greater) on 13 cases under high magnification and intraoperative facial nerve monitoring, and the other 6 cases who were found to have unclear border between nerve shaft and the tumors underwent total tumor removal and nerve grafting. They were divided into the near-total removal group and the total removal group, and followed up for 7.38 ± 1.98 years (range, 5 to 11 years) and 6.66 ± 1.63 years (range, 5 to 9 years), respectively. MRI examination was performed on each patient before surgery, three months after surgery and each year thereafter. Hearing level was measured by audiometer.


During the surgery, intraoperative facial nerve monitoring was used to identify facial nerve from the tumors. A cut was made through the tumors near its junction with facial nerve. The tumor capsule was left, and other tumor tissues were all removed. Nerve sheath was preserved.


The selection of surgical approach was mainly dependent on tumor location. Middle cranial fossa approach was selected when the tumors affected internal auditory canal segment, cerebellar pontine angle segment, labyrinthine segment or geniculate ganglion of facial nerve, and transmastoid approach was considered when tympanic segment or mastoid segment was affected. Middle cranial fossa combined with transmastoid approach was adopted when both the former and latter sites were involved. There were no noticeable complications.





Materials and methods


A consecutive series of 19 FNS patients with good facial nerve function was involved in the study, among which 11 were female and 8 male. The mean age was 36.20 ± 3.22 years (range, 18 to 72 years). We successfully carried out near-total removal of FNS (defined as tumor removal of 95 percentage or greater) on 13 cases under high magnification and intraoperative facial nerve monitoring, and the other 6 cases who were found to have unclear border between nerve shaft and the tumors underwent total tumor removal and nerve grafting. They were divided into the near-total removal group and the total removal group, and followed up for 7.38 ± 1.98 years (range, 5 to 11 years) and 6.66 ± 1.63 years (range, 5 to 9 years), respectively. MRI examination was performed on each patient before surgery, three months after surgery and each year thereafter. Hearing level was measured by audiometer.


During the surgery, intraoperative facial nerve monitoring was used to identify facial nerve from the tumors. A cut was made through the tumors near its junction with facial nerve. The tumor capsule was left, and other tumor tissues were all removed. Nerve sheath was preserved.


The selection of surgical approach was mainly dependent on tumor location. Middle cranial fossa approach was selected when the tumors affected internal auditory canal segment, cerebellar pontine angle segment, labyrinthine segment or geniculate ganglion of facial nerve, and transmastoid approach was considered when tympanic segment or mastoid segment was affected. Middle cranial fossa combined with transmastoid approach was adopted when both the former and latter sites were involved. There were no noticeable complications.





Results


Summary of the patients in near-total removal group and total removal group is in Tables 1 and 2 . Facial paralysis was firstly presented in 14 of 19 cases (73.7%), followed by hearing loss in 9 of 19 cases (45.0%) and vertigo in 2 of 19 cases (10.5%). Geniculate ganglion and/or labyrinthine segment were most commonly affected (12 cases, 63.2%), followed by tympanic segment (8 cases, 42.1%), mastoid segment (7 cases, 36.8%), internal auditory canal segment (7 cases, 36.8%), and CPA segment (one case, 5.3%). Multi-segment involvement (12 cases, 63.2%) was more common than single-segment involvement.



Table 1

Summary of 13 cases who underwent near-total tumor removal.






























































































































































No. Symptoms Segments affected PreFNF PosFNF Surgical approach Initial hearing level Final hearing level Recurrence Follow-up (years)
1 SNHL, T IAC II II MCF 30 dB 30 dB No 6
2 FP IAC II II MCF Normal Normal No 8
3 FP, V GG, LS II II MCF Normal Normal No 6
4 FP, CHL GG, TS, MS III IV TM, MCF 40 dB 25 dB No 5
5 T, MHL LS, TS, MS I I TM, MCF 35 dB 30 dB No 7
6 T IAC, GG I I MCF Normal Normal Yes 9
7 FP CPA III II MCF Normal Normal No 7
8 CHL, T TS, MS I I TM 30 dB 20 dB No 5
9 FP GG, TS II II TM, MCF Normal Normal No 8
10 CHL, T LS, TS, MS I I TM, MCF 40 dB 25 dB No 9
11 FP, CHL GG, TS, MS III II TM, MCF 55 dB 30 dB No 10
12 FP IAC III III MCF Normal Normal No 11
13 PF GG II I MCF Normal Normal No 5

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Aug 23, 2017 | Posted by in OTOLARYNGOLOGY | Comments Off on Near-total removal of facial nerve schwannomas: long-term outcomes

Full access? Get Clinical Tree

Get Clinical Tree app for offline access